DUPONT ACA VANCOMYCIN (VANC) METHOD
K-Number: K945125 · 1995-03-10
Advertisement
Device Summary
Frequently Asked Questions
What is the DUPONT ACA VANCOMYCIN (VANC) METHOD?
DUPONT ACA VANCOMYCIN (VANC) METHOD is a medical device that received FDA 510(k) clearance on 1995-03-10. The listed applicant is The DU Pont Co.. The 510(k) number is K945125.
When did DUPONT ACA VANCOMYCIN (VANC) METHOD receive FDA 510(k) clearance?
DUPONT ACA VANCOMYCIN (VANC) METHOD received FDA 510(k) clearance on 1995-03-10, under 510(k) number K945125.
Who is the listed applicant for DUPONT ACA VANCOMYCIN (VANC) METHOD?
The FDA 510(k) record lists The DU Pont Co. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for DUPONT ACA VANCOMYCIN (VANC) METHOD?
The FDA product code for DUPONT ACA VANCOMYCIN (VANC) METHOD is LEH.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing The DU Pont Co. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LEH)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement